Company news

United Therapeutics Corporation news in 2025

United Therapeutics Corporation's news releases, calls and decks from 2025, newest first.

View company

United Therapeutics Corporation to Present at Upcoming Investor Conferences

November 3, 2025

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

November 2, 2025

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

October 28, 2025

United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025

October 14, 2025

United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting

October 12, 2025

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

September 18, 2025

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

September 15, 2025

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

September 11, 2025

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

September 1, 2025

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 28, 2025

3D Systems Reports Second Quarter 2025 Financial Results

August 11, 2025

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

July 31, 2025

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

July 29, 2025

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

July 15, 2025

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

June 23, 2025

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

June 22, 2025

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

April 29, 2025

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

April 20, 2025

United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025

April 15, 2025

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

April 3, 2025

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

April 1, 2025

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

March 3, 2025

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

February 25, 2025

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

February 23, 2025

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

February 18, 2025

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

February 3, 2025

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

February 2, 2025

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

January 20, 2025

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 5, 2025

Calls in 2025

Decks in 2025